Insulin Glargine at Bedtime or in AM Versus NPH

PHASE4CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

1- Insulin glargine QHS

Insulin glargine at bedtime (dose titrated to maintain 50% of fasting glucose readings \<120 mg/dL)

DRUG

2 - Insulin glargine QAM

Insulin glargine in AM (dose titrated to maintain 50% of pre-supper glucose readings \<120 mg/dL)

DRUG

3 - NPH insulin QHS

NPH insulin at bedtime (dose titrated to maintain 50% of fasting glucoses \<120 mg/dL)

Trial Locations (1)

90059

Charles Drew University of Medicine and Science, Los Angeles

All Listed Sponsors
collaborator

National Center for Research Resources (NCRR)

NIH

lead

Charles Drew University of Medicine and Science

OTHER

NCT00686712 - Insulin Glargine at Bedtime or in AM Versus NPH | Biotech Hunter | Biotech Hunter